BioNTech SE (BNTX) DCF Valuation

BioNTech SE (BNTX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

BioNTech SE (BNTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify BioNTech SE (BNTX) valuation with this customizable DCF Calculator! With actual BioNTech SE (BNTX) financials and adjustable forecast inputs, you can test scenarios and reveal BioNTech SE (BNTX) fair value in just minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 113.2 502.8 19,781.8 18,045.0 3,981.0 5,108.5 6,555.2 8,411.7 10,793.9 13,850.8
Revenue Growth, % 0 344.17 3834.42 -8.78 -77.94 28.32 28.32 28.32 28.32 28.32
EBITDA -158.8 -109.6 15,638.8 12,954.3 1,133.7 587.8 754.3 967.9 1,242.0 1,593.8
EBITDA, % -140.25 -21.79 79.06 71.79 28.48 11.51 11.51 11.51 11.51 11.51
Depreciation 35.2 37.6 81.5 126.2 191.2 454.9 583.7 749.0 961.1 1,233.3
Depreciation, % 31.12 7.48 0.41208 0.69945 4.8 8.9 8.9 8.9 8.9 8.9
EBIT -194.0 -147.2 15,557.3 12,828.1 942.6 450.9 578.6 742.5 952.8 1,222.6
EBIT, % -171.38 -29.27 78.64 71.09 23.68 8.83 8.83 8.83 8.83 8.83
Total Cash 542.9 1,404.6 2,162.3 14,661.2 17,251.1 4,006.9 5,141.6 6,597.8 8,466.3 10,864.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 12,907.0 7,448.8 2,252.3
Account Receivables, % 0 0 65.25 41.28 56.58
Inventories 12.2 66.8 523.8 458.3 372.9 394.8 506.6 650.1 834.2 1,070.5
Inventories, % 10.79 13.29 2.65 2.54 9.37 7.73 7.73 7.73 7.73 7.73
Accounts Payable 21.4 106.6 166.8 212.8 369.0 524.9 673.6 864.4 1,109.1 1,423.3
Accounts Payable, % 18.88 21.21 0.84314 1.18 9.27 10.28 10.28 10.28 10.28 10.28
Capital Expenditure -74.1 -89.1 -160.5 -378.7 -735.4 -1,068.3 -1,370.8 -1,759.0 -2,257.2 -2,896.4
Capital Expenditure, % -65.46 -17.72 -0.81152 -2.1 -18.47 -20.91 -20.91 -20.91 -20.91 -20.91
Tax Rate, % 21.57 21.57 21.57 21.57 21.57 21.57 21.57 21.57 21.57 21.57
EBITAT -193.7 15.3 10,642.0 9,342.7 739.3 288.2 369.8 474.5 608.9 781.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -223.4 -5.4 -2,740.9 14,659.9 5,633.2 394.6 -852.4 -1,093.8 -1,403.5 -1,801.0
WACC, % 5.66 5.63 5.65 5.65 5.65 5.65 5.65 5.65 5.65 5.65
PV UFCF
SUM PV UFCF -3,812.6
Long Term Growth Rate, % 3.50
Free cash flow (T + 1) -1,864
Terminal Value -86,729
Present Terminal Value -65,892
Enterprise Value -69,704
Net Debt -11,930
Equity Value -57,774
Diluted Shares Outstanding, MM 243
Equity Value Per Share -238.05

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real BNTX financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on BioNTech’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Pre-Loaded Data: BioNTech SE’s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins.
  • Instant Results: Watch BioNTech SE’s intrinsic value recalculate in real time.
  • Clear Visual Outputs: Dashboard charts showcase valuation results and key metrics.
  • Built for Accuracy: A professional tool tailored for analysts, investors, and finance experts.

How It Works

  • Step 1: Download the prebuilt Excel template featuring BioNTech SE’s (BNTX) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the key metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including BioNTech SE’s (BNTX) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports using the generated outputs.

Why Choose This Calculator for BioNTech SE (BNTX)?

  • Tailored for Experts: A specialized tool designed for researchers, investors, and biotech analysts.
  • Comprehensive Data: BioNTech’s historical and anticipated financials integrated for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Detailed Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience.

Who Should Use This Product?

  • Biotechnology Students: Explore drug development processes and apply them using real-world data.
  • Researchers: Integrate advanced models into studies or academic projects focused on mRNA technology.
  • Investors: Validate your investment strategies and evaluate valuation metrics for BioNTech SE (BNTX).
  • Financial Analysts: Enhance your analysis with a ready-to-use, customizable valuation model specifically for biotech firms.
  • Healthcare Entrepreneurs: Understand how large biotech companies like BioNTech SE (BNTX) are assessed in the market.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for BioNTech SE (BNTX).
  • Real-World Data: BioNTech’s historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to BioNTech SE (BNTX).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding BioNTech SE (BNTX).

No products were found matching.